Lilly profit beats forecast

April 24 Wed Apr 24, 2013 6:39am EDT

April 24 (Reuters) - Eli Lilly and Co on Wednesday reported higher-than-expected first-quarter earnings, helped by sales of its treatments for diabetes, depression and lung cancer.

The company said it had net income of $1.55 billion, or $1.42 per share. That compared with $1.01 billion, or 91 cents per share, in the year-earlier period.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.